Manufacturing . net

Medical

Subscribe to Medical
View Sample

FREE Email Newsletter

Today in Manufacturing

Daily news and top headlines for manufacturing professionals

Contract Manufacturing And Recalls

May 7, 2012 12:18 pm | by Mike Rozembajgier, Vice President of Recalls, StericycleExpertRECALL | Articles | Comments

Pharmaceutical companies face increased competition to meet consumer demand, which means tighter and more complex deals with contract manufacturers.

NIH, Companies Aim To Teach Old Drugs New Tricks

May 3, 2012 2:08 pm | by Lauran Neergaard, AP Medical Writer | News | Comments

Pfizer, AstraZeneca and Eli Lilly & Co. are dusting off two dozen old drugs that failed to treat one disease but might treat another.

Impax Labs Falls On Weak Sales, New FDA Warning

May 2, 2012 9:27 am | News | Comments

The FDA recently issued a Form 483, which said inspectors found problems in Impax's quality control laboratory.

Advertisement

US Approves Antibiotic To Treat, Prevent Plague

April 30, 2012 9:38 am | by the Associated Press | News | Comments

The Johnson & Johnson antibiotic is able to cure a vast majority of the rare bacterial infections, which could be use as a potential bioterrorism agent.

Hologic Buying Gen-Probe For About $3.72B

April 30, 2012 8:47 am | News | Comments

Medical device maker Hologic Inc. said Monday that it will buy diagnostic test maker Gen-Probe for about $3.72 billion in an all-cash deal.

Novo Nordisk To Expand U.S. Workforce By 15 Pct.

April 27, 2012 2:18 pm | News | Comments

The company will look to fill positions at its new type 1 diabetes research center in Seattle and at a manufacturing plant in North Carolina.

New J&J CEO Plans Realistic, Optimistic Future

April 26, 2012 9:23 am | by Linda A. Johnson, AP Business Writer | News | Comments

New CEO Alex Gorsky said one of his short-term priorities is to get "reliable" consumer products back on store shelves.

Alabama Restricts Cold Medicines To Stop Meth

April 20, 2012 2:00 pm | by Phillip Rawls, Associated Press | News | Comments

The bill is the latest in recent years to try to slow down meth production, which uses cold and allergy medicine containing ephedrine or pseudoephedrine.

Advertisement

Does Giving Antibiotics To Animals Hurt Humans?

April 20, 2012 1:45 pm | by Matthew Perrone, AP Health Writer | News | Comments

Antibiotics have saved countless lives in treating a variety of diseases, but some argue their use in meat breeds antibiotic-resistant germs.

Medical Firm To Build Plasma Plant In Georgia

April 19, 2012 9:35 am | by Errin Haines, Associated Press | News | Comments

Baxter International Inc. will employ about 1,500 people to make plasma-based therapies that treat chronic and life-threatening illnesses.

EU Clears J&J's $21.3BN Synthes Acquisition

April 19, 2012 8:31 am | News | Comments

The European Union's competition regulator says it has approved Johnson & Johnson's $21.3 billion acquisition of Swiss orthopedics maker Synthes.

High Court Weighs Overtime Pay For Drug Sales Reps

April 17, 2012 9:38 am | by Mark Sherman, Associated Press | News | Comments

The justices questioned whether the federal law governing overtime pay should apply to those who try to persuade doctors to prescribe certain drugs.

Accelerating Production

April 16, 2012 1:00 pm | by Jonnatha Mayberry, Associate Editor, Chem.Info | Articles | Comments

Unable to produce much-needed vaccines with its limited production capacity, Merck decided to rapidly increase its manufacturing capabilities.

Engineering The Future

April 13, 2012 12:34 pm | by Mike Auerbach, Editor in Chief, Pharmaceutical Processing | Blogs | Comments

When designing pharmaceutical facilities, there is much to be taken into consideration, and merely throwing up a "bunch of bricks" just doesn't cut it anymore.

FDA Adds New Side Effects To Finasteride Label

April 12, 2012 2:49 pm | News | Comments

The main ingredient in the male baldness treatment Propecia is responsible, the FDA says, for side effects that linger after patients stop taking the drug.

Amgen To Buy KAI Pharma For $315M

April 10, 2012 1:48 pm | News | Comments

The world's biggest biotech drugmaker will help KAI finish planning late stage trials of its most advanced drug candidate, which helps dialysis patients.

Cook Group Acquires Biotech Company

April 10, 2012 9:05 am | News | Comments

Medical device maker Cook Group has bought an Indianapolis company that specializes in cell and tissue processing and cryopreservation technologies.

FDA Finds More Vials Of Fake Cancer Drug

April 4, 2012 1:17 pm | News | Comments

The vials are packaged as Altuzan, the Turkish version of Avastin that is not approved for use in the U.S.

Medtronic Pays $85M To End Shareholder Lawsuit

April 2, 2012 8:58 am | News | Comments

Medical device maker Medtronic Inc. has agreed to pay $85 million to resolve a federal class action lawsuit brought by a group of shareholders.

Roche Raises Bid For Illumina

March 29, 2012 9:11 am | News | Comments

Swiss pharmaceutical company raised its offer for Illumina to $51 cash per share, in a bid to speed up a takeover of the U.S. diagnostics company.

Allergan Says Botox Works In Incontinence Study

March 28, 2012 2:25 pm | News | Comments

In a recent test, the popular wrinkle remover and spasm suppressant worked better than a placebo as a treatment for an overactive bladder.

Cypress Pharma Settles Marketing Case For $2.8M

March 28, 2012 2:00 pm | News | Comments

The government alleges that a Cypress subsidiary falsely claimed that three skin products carried the FDA's "safe and effective" designation.

Trial Begins In Arkansas Over Anti-Psychotic Drug

March 27, 2012 2:18 pm | by Allen Reed, Associated Press | News | Comments

An attorney has asked jurors to hold a J&J subsidiary financially liable for allegedly concealing risks associated with its anti-psychotic drug Risperdal.

Ala. Judge Sets Trial Dates For Suits Over Chantix

March 27, 2012 9:41 am | News | Comments

The first two trials of more than 2,400 lawsuits nationwide accuse the drug, which was made by Pfizer, of causing the patient to commit suicide.

FDA Outlines MAP Inc. Drug Issues

March 27, 2012 9:28 am | News | Comments

The FDA asked the Mountain View, Calif.-based company to address "observations from a recent facility inspection of a third party manufacturer."

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading